QualityStocksNewsBreaks Archives - Page 1032 of 1577

ThursdayAug 27, 2020 2:36 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) to Offer Esketamine for Treatment of Adults with MDD at Flagship Clinic

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), today announced that it is expanding its rapid-onset treatment service for major depressive disorder (“MDD”). According to the update, Champignon will offer esketamine for the treatment of adults with MDD at its flagship clinic, the Canadian Rapid Treatment Centre of Excellence (“CRTCE”), starting in September 2020. Declared a breakthrough treatment for depression by the US Food and Drug Administration (“FDA”), esketamine was approved by Health Canada for the treatment of MDD in May 2020. “The availability of esketamine at the CRTCE provides tremendous opportunity for adults across Canada affected by treatment-resistant depression…

ThursdayAug 27, 2020 1:02 pm

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Bit5ive Partnership Is ‘Big Deal for ISWH Shares’

ISW Holdings (OTC: ISWH), a global brand-management portfolio company with diverse partnerships, is entering a promising new space just in time for the revolution in turnkey crypto-mining solutions (http://ibn.fm/9ELRZ). A recent article discussing this covers a TradingView report that highlights the company’s opportunity and optimal timing through a recent collaboration it deems a “big deal for ISWH shares.” The piece reads, “ISW Holdings Inc. has entered the crypto-mining equipment industry by virtue of its recent joint venture partnership with Bit5ive LLC, a global top player in the space developing, running and selling what are known as ‘turnkey mining solutions.’ This is…

ThursdayAug 27, 2020 12:39 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) and TumorGenesis Advancing Path Toward Patient-Specific Treatments

Predictive Oncology (NASDAQ: POAI), together with its TumorGenesis subsidiary, has achieved significant breakthroughs in applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Earlier in June, TumorGenesis, which is developing a new rapid approach to growing tumors in the laboratory, sold its first order of unique ovarian cancer cell culture media to a New England-based university carrying out research within the sector (http://ibn.fm/lpsCk). A recent article discussing POAI and TumorGenesis reads, “Predictive Oncology focuses on building AI-driven predictive models of tumor drug response and outcomes from its database of drug-response and genomic profiles gathered from more than 150,000…

ThursdayAug 27, 2020 10:30 am

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Announces Participation Schedule for September Investor Conferences

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, recently announced its plans to participate in investor conferences during the month of September 2020. According to the update, SGLB will participate in the LD 500 Virtual Investor Conference slated to take place from September 1-4, 2020, and the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020. Sigma Labs CEO Mark K. Ruport will host a virtual presentation and participate in one-on-one meetings, and management will highlight its recent contract award with Mitsubishi Heavy Industries and other end users in a…

ThursdayAug 27, 2020 10:07 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) VP Scheduled to Present During Prestigious LD 500 Virtual Event

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a B2B global vendor of next-generation, push-to-talk over cellular (“PTT”) devices and cellular booster systems, will be participating at the upcoming LD 500 Virtual Conference. The four-day gathering, slated for Sept. 1–4, 2020, and featuring some of the most prominent companies in the micro-cap world, is the most ambitious event yet for the LD event group. Siyata Mobile’s vice president of corporate development, Daniel Kim, will be presenting during the premiere event, held online for the first time. His 20-minute live presentation is scheduled for Friday, Sept. 4, at 6:20 a.m. PST (9:20 a.m.…

WednesdayAug 26, 2020 2:47 pm

QualityStocksNewsBreaks – Cybin Corp. Poised Amid Groundbreaking Decision to Allow Psilocybin Therapy

Cybin Corp., an exemplary Canada-based life-science company focused on the development of pharmaceutical-grade psilocybin products, appears ideally positioned to leverage a milestone moment. Canada’s Minister of Health, the Honourable Patty Hajdu, recently approved the use of psilocybin therapy in the end-of-life treatment of four Canadians battling incurable cancer (http://ibn.fm/0BUOU), and this groundbreaking decision bodes well for companies such as Cybin, which are operating in the sector. The approval marks the first known, legal medical exemption for psilocybin use in Canada since the compound became illegal in the country in 1974. A recent article discussing this anticipates more applications through the exemption…

WednesdayAug 26, 2020 2:11 pm

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Positioned to Compete in ‘Largely Untapped US Market’

DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, recently completed a round of successful fundraising that will assist in expanding the availability of its platform. DarioHealth secured approximately $28.6 million in aggregate gross proceeds from health-care funds and institutions across the United States and Israel through the private-placement transaction with accredited investors. The new capital coupled with existing cash puts the company in its best financial state since its inception (http://ibn.fm/uKWvc). A recent article discussing this quotes Dario CEO Erez Raphael, who stated, “We are pleased to have the confidence of our largest shareholder and…

WednesdayAug 26, 2020 1:54 pm

QualityStocksNewsBreaks – Deltec Bank & Trust Ltd. Delves Into Intricacies Surrounding EU Recovery Fund

Deltec Bank & Trust, recently named the Best Private Bank Caribbean 2020 (http://ibn.fm/PS1F4), has published its latest investment research note entitled “EUreka” (http://ibn.fm/UhKNZ). In the piece, Deltec looks into the intricacies around the European Union’s (“EU”) proactive fiscal response in dealing with the ongoing coronavirus outbreak and its impact on Eurozone financial-asset prices and the Euro. Deltec believes that the EU’s actions will benefit the government bonds and Europe’s weaker economies in the long term, with over-strained fiscal budgets set to be subsidized by the recovery-fund mechanism. A recent article discussing this reads, “Today, following the historic introduction of the €750…

WednesdayAug 26, 2020 12:10 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Products Available Through Largest US Food Redistribution Company

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) has announced that its products will be carried by Dot Foods Inc., the largest food redistribution company in the United States. This entry into the hospitality space includes the company’s Alkaline88(R) and A88 Infused(TM) lines as well as its aluminum bottles. A producer of premium bottled alkaline water, flavor-infused waters, and CBD-infused products, WTER said these products will be available nationwide to Dot Foods’ 4,300 customers around the country by Sept. 21, 2020. “Adding the largest food-service redistributor, Dot Foods, to our growing list of channel partners is another milestone for the company,”…

WednesdayAug 26, 2020 11:08 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Invited to Present at Prestigious LD 500 Virtual Investor Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has announced that it joins the lineup of presenters at this year’s LD 500 Virtual Investor Conference. The annual LD Conference spotlights some of the most prominent companies in the micro-cap world, and also includes interviews and keynotes with small-cap leaders. GNPX chairman and CEO Rodney Varner will provde a company overview as well as updates on Genprex’s lead drug candidate, GPX-001, which recently received fast track designation from the U.S. Food and Drug Administration for use in combination with AstraZeneca's Tagrisso(R) for…

Site Search

Company Search

Category: QualityStocksNewsBreaks